Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.

Br J Cancer · 2005 · PMC2361836 · PMID 15655539

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

In addition to there being little effect on normal vasculature there may be significant therapeutic implications in that AW464 may have to be administered chronically or in combination with other agents rather than it being used acutely if it were a tumour vascular targeting agent.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.